Outlook Therapeutics, Inc. - Common Stock (OTLK)

Last Price0.4199

Change+0.1100 (35.50%)

NASDAQ· Last Trade: May 26th, 10:47 AM EDT

Detailed Quote

Previous Close	0.3099
Open	0.4650
Bid	0.4194
Ask	0.4199
Day's Range	0.3930 - 0.4653
52 Week Range	0.1611 - 3.390
Volume	222,534,262
Market Cap	22.63M
PE Ratio (TTM)	-0.1603
EPS (TTM)	-2.6
Dividend & Yield	N/A (N/A)
1 Month Average Volume	5,208,954

About Outlook Therapeutics, Inc. - Common Stock (OTLK)

Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for eye diseases. The company specializes in the research and advancement of therapies aimed at addressing significant unmet medical needs in ophthalmology. Through its proprietary drug pipeline, Outlook Therapeutics is committed to enhancing the quality of life for patients affected by various retinal conditions, striving to bring new possibilities and improved outcomes to vision care. Read More

Outlook Therapeutics, Inc. - Common Stock (OTLK)

Detailed Quote

Chart

About Outlook Therapeutics, Inc. - Common Stock (OTLK)

News & Press Releases